Abstract
Biotransformation is integral part of a living system. The system is built upon materials which are absorbed and transformed into the organic and inorganic building blocks and the unwanted or/and toxic materials are transformed and eliminated out of the system. These biotransformations are a part of multistep process containing specific enzymes and reactions catalyzed by them. Further these reactions and transformations are governed by biological factors, physiochemical properties, etc. of the system and materials which are taken in. Therefore, biotransformations can be used as technical strategy for pollution abatement, production of pharmaceutics, compounds especially for chemical and agricultural industry, etc. The current chapter delineates different phases of biotransformation process, the enzymes and their applications in industry and briefly sums up the current status of available research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bai X, Moraes TF, Reithmeier RA (2017) Structural biology of solute carrier (SLC) membrane transport proteins. Mol Membr Biol 34(1–2):1–32
Bianchini LF, Arruda MF, Vieira SR et al (2015) Microbial biotransformation to obtain new antifungals. Front Microbiol 6:1433
Buhler DR, Williams DE (1988) The role of biotransformation in the toxicity of chemicals. Aquat Toxicol 11(1–2):19–28
David JP, Peter GF, Miners JO (2005) “Phase I and phase II” drug metabolism: terminology that we should phase out? Drug Metab Rev 37(4):575–580
Doelle HW, Rokem JS, Berovic M (2009) Biotechnology: fundamentals in biotechnology. EOLSS Publications, Oxford, p 10
Döring B, Petzinger E (2014) Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism. Drug Metab Rev 46(3):261–282
Fan LL, Li HJ, Chen QH (2014) Applications and mechanisms of ionic liquids in whole-cell biotransformation. Int J Mol Sci 5(7):12196–12216
Gao F, Zhang JM, Wang ZG et al (2013) Biotransformation, a promising technology for anti-cancer drug development. Asian Pac J Cancer Prev 14(10):5599–5608
Gaynes BI, Fiscella RG (1996) Biotransformation in review: applications in ocular disease and drug design. J Ocul Pharmacol Ther 12(4):527–539
Hacker M, Messer WS, Bachmann KA (2009) Pharmacology: principles and practice. Academic Press, Amsterdam
Hansen TWR, Bratlid D (1986) Bilirubin and brain toxicity. Acta Paediatr 75(4):513–522
Hediger MA, Romero MF, Peng JB, Rolfs A, Takanaga H, Bruford EA (2004) The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins. Pflugers Arch 447(5):465–468
Hediger MA, Clémençon B, Burrier RE, Bruford EA (2013) The ABCs of membrane transporters in health and disease (SLC series): introduction. Mol Aspects Med 34(2–3):95–107
Hellstén S (2013) Recovery of biomass-derived valuable compounds using chromatographic and membrane separations. Acta Universitatis Lappeenrantaensis, Tampere
Ishikawa T (1992) The ATP-dependent glutathione S-conjugate export pump. Trends Biochem Sci 17(11):463–468
Jancova P, Anzenbacher P, Anzenbacherova E et al (2010) Phase II drug metabolizing enzymes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 154(2):103–116
Kebamo S, Tesema S, Geleta B (2015) The role of biotransformation in drug discovery and development. J Drug Metab Toxicol 6(196):2
Kuntz E (2008) Hepatology: textbook and atlas. Springer, Berlin, p 38
Lech JJ, Vodicnik MJ (1985) Biotransformation. In: Fundamentals of aquatic toxicology: methods and applications. Hemisphere Publishing Corporation, Washington, pp 526–557
Lilly MD (1992) The design and operation of biotransformation processes. In: Vardar-Sukan F, Sukan ŞS (eds) Recent advances in biotechnology, vol 210. Kluwer, Dordrecht, pp 47–68
Lin B, Tao Y (2017) Whole-cell biocatalysts by design. Microb Cell Fact 16(1):106
Liska DJ (1998) The detoxification enzyme systems. Altern Med Rev 3(3):187–198
McDonald AG, Boyce S, Tipton KF (2001) Enzyme classification and nomenclature. eLS 83:289–300
Pang KS, Kwan KC (1983) A commentary: methods and assumptions in the kinetic estimation of metabolite formation. Drug Metab Dispos 11(2):79–84
Parkinson A (2001) Biotransformation of xenobiotics. McGraw-Hill, New York
Peeples TL (2014) Bioremediation using extremophiles. In: Microbial biodegradation and bioremediation. Elsevier, Amsterdam, pp 251–268
Pelikan EW (2004) Glossary of terms and symbols used in pharmacology. University School of Medicine, Department of Pharmacology and Experimental Therapeutics, Boston
Petzinger E, Geyer J (2006) Drug transporters in pharmacokinetics. Naunyn Schmiedebergs Arch Pharmacol 372(6):465–475
Ren Q, Paulsen IT (2005) Comparative analyses of fundamental differences in membrane transport capabilities in prokaryotes and eukaryotes. PLoS Comput Biol 1(3):e27
Renton KW (1986) Factors affecting drug biotransformation. Clin Biochem 19(2):72–75
Schonborn JL, Gwinnutt C (2010) The role of liver in drug metabolism. Anesth Tutor Week 179:1–6
Seeger M, González M, Cámara B et al (2003) Biotransformation of natural and synthetic isoflavonoids by two recombinant microbial enzymes. Appl Environ Microbiol 69(9):5045–5050
Sellers EM, Holloway MR (1978) Drug kinetics and alcohol ingestion. Clin Pharmacokinet 3(6):440–452
Sicurella S, Farrell P (2017) SCIEX announces new biotransformation solutions for routine and comprehensive metabolism and biologic catabolism studies. SCIEX, Thornhill
Smitha MS, Singh S, Singh R (2017) Microbial biotransformation: a process for chemical alterations. J Bacteriol Mycol 4(2):85
Song Z (2018) A bibliometric analysis of research updates and tendencies on steroid biotransformation. IOP Conf Ser: Earth Environ Sci 128:012132
Sultana N, Saify ZS (2013) Enzymatic biotransformation of terpenes as bioactive agents. J Enzyme Inhib Med Chem 28(6):113–1128
Timbrell JA, Marrs TC (2009) Biotransformation of xenobiotics. In: General, applied and systems toxicology. Wiley, New York
Vasic-Racki D (2006) History of industrial biotransformations—dreams and realities. In: Industrial biotransformations. Wiley, London, pp 1–35
Vīna I, Linde R, Patetko A, Semjonovs P (2013) Glucuronic acid from fermented beverages: biochemical functions in humans and its role in health protection. Int J Recent Res Appl Stud 14(2):217–230
Vrbanac J, Slauter R (2013) ADME in drug discovery. In: Faqi AS (ed) A comprehensive guide to toxicology in preclinical drug development. Academic Press, Amsterdam
Walker HK, Hall WD, Hurst JW (1990) In: Stillman AE (ed) Clinical methods: the history, physical, and laboratory examinations, 3rd edn. Butterworths, Boston
Williams RT (1959) Detoxication mechanisms: the metabolism and detoxication of drugs, toxic substances, and other organic compounds. Wiley, London
Acknowledgments
We acknowledge all the authors whose articles have been cited in the text.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Yashavarddhan, M.H., Bajaj, S., Shukla, S.K., Vibhuti, A. (2021). Biotransformation: Basics and Applied Perspectives. In: Singh, A., Srivastava, S., Rathore, D., Pant, D. (eds) Environmental Microbiology and Biotechnology. Springer, Singapore. https://doi.org/10.1007/978-981-15-7493-1_16
Download citation
DOI: https://doi.org/10.1007/978-981-15-7493-1_16
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-7492-4
Online ISBN: 978-981-15-7493-1
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)